Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 32
2022 38
2023 22
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia.
Roberts T, Uwenedi G, Bruton R, McIlroy G, Damery S, Sylla P, Logan N, Scott S, Lau M, Elzaidi A, Plass S, Mallick S, Spencer K, Stephens C, Bentley C, Pratt G, Zuo J, Paneesha S, Willett B, Moss P, Parry H. Roberts T, et al. Blood Cancer J. 2024 Jan 25;14(1):22. doi: 10.1038/s41408-023-00940-5. Blood Cancer J. 2024. PMID: 38272915 Free PMC article. No abstract available.
Accelarated immune ageing is associated with COVID-19 disease severity.
Lord JM, Veenith T, Sullivan J, Sharma-Oates A, Richter AG, Greening NJ, McAuley HJC, Evans RA, Moss P, Moore SC, Turtle L, Gautam N, Gilani A, Bajaj M, Wain LV, Brightling C, Raman B, Marks M, Singapuri A, Elneima O, Openshaw PJM, Duggal NA; PHOSP-COVID Study collaborative group; ISARIC4C investigators. Lord JM, et al. Immun Ageing. 2024 Jan 11;21(1):6. doi: 10.1186/s12979-023-00406-z. Immun Ageing. 2024. PMID: 38212801 Free PMC article.
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, Joy M, Crawford A, Goudie R, Byford R, Abbasizanjani H, Smith D, Laidlaw L, Akbari A, Sullivan C, Bradley DT, Lyons RA, de Lusignan S, Hobbs FDR, Robertson C, Sheikh SA, Shi T. Bedston S, et al. Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38162515 Free PMC article.
VarLOCK: sequencing-independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance.
Nan X, Hardinge P, Hoehn S, Dighe SN, Ukeri J, Pease DF, Griffin J, Warrington JI, Saud Z, Hottinger E, Webster G, Jones D, Kille P, Weightman A, Stanton R, Castell OK, Murray JAH, Jurkowski TP. Nan X, et al. Sci Rep. 2023 Nov 27;13(1):20832. doi: 10.1038/s41598-023-47289-0. Sci Rep. 2023. PMID: 38012215 Free PMC article.
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Brightling CE, Evans RA, Singapuri A, Smith N, Wain LV; PHOSP-COVID Collaborative Group. Brightling CE, et al. Lancet Respir Med. 2023 Nov;11(11):e93-e94. doi: 10.1016/S2213-2600(23)00341-7. Epub 2023 Oct 16. Lancet Respir Med. 2023. PMID: 37858329 No abstract available.
Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
Dowell AC, Tut G, Begum J, Bruton R, Bentley C, Butler M, Uwenedi G, Zuo J, Powell AA, Brent AJ, Brent B, Baawuah F, Okike I, Beckmann J, Ahmad S, Aiano F, Garstang J, Ramsay ME, Moss P, Ladhani SN. Dowell AC, et al. J Infect. 2023 Nov;87(5):403-412. doi: 10.1016/j.jinf.2023.08.013. Epub 2023 Sep 3. J Infect. 2023. PMID: 37660754 Free article.
86 results